| Aktie | Ticker | Breite | GCS | 2026/Q2 | 2026/Q1 | 2025/Q4 | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Investment ($) | QoQ ($) | QoQ (%) | Anz. Fonds | Investment ($) | QoQ ($) | QoQ (%) | Anz. Fonds | Investment ($) | QoQ ($) | QoQ (%) | Anz. Fonds | ||||
| Gesamt | 624.441.478 $ | -279.719.560 $ | -26,4 % | 45 | 935.701.174 $ | +640.736.346 $ | +210,1 % | 52 | 346.693.009 $ | -27.221.291 $ | -6,5 % | 39 | |||
| Dianthus Therapeutics, Inc. /DE/ | DNTH | → 0 | Schwach | 205.115.856 $ | -156.214.620 $ | -43,2 % | 1 | 361.330.476 $ | +274.617.053 $ | +316,7 % | 1 | 86.713.423 $ | -39.371.217 $ | -31,2 % | 1 |
| CG Oncology, Inc. | CGON | → 0 | Schwach | 99.395.255 $ | +12.159.254 $ | +13,9 % | 1 | 87.236.001 $ | +26.089.539 $ | +42,7 % | 1 | 61.146.462 $ | -3.337.750 $ | -5,2 % | 1 |
| Oruka Therapeutics, Inc. | ORKA | → 0 | Neutral | 72.369.552 $ | -16.949.851 $ | -19,0 % | 1 | 89.319.403 $ | +69.301.952 $ | +346,2 % | 1 | 20.017.451 $ | +7.317.497 $ | +57,6 % | 1 |
| Jade Biosciences, Inc. | JBIO | → 0 | Schwach | 37.789.732 $ | -16.067.490 $ | -29,8 % | 1 | 53.857.222 $ | +32.244.298 $ | +149,2 % | 1 | 21.612.924 $ | +11.885.309 $ | +122,2 % | 1 |
| Perspective Therapeutics, Inc. | CATX | → 0 | Schwach | 21.482.997 $ | -27.340.495 $ | -56,0 % | 1 | 48.823.492 $ | +39.993.976 $ | +453,0 % | 1 | 8.829.516 $ | -1.440.017 $ | -14,0 % | 1 |
| Enliven Therapeutics, Inc. | ELVN | → 0 | Neutral | 27.912.500 $ | -4.259.500 $ | -13,2 % | 1 | 32.172.000 $ | +30.011.380 $ | +1.389,0 % | 1 | 2.160.620 $ | -711.321 $ | -24,8 % | 1 |
| Context Therapeutics Inc. | CNTX | → 0 | Neutral | 2.768.540 $ | -22.122.830 $ | -88,9 % | 1 | 24.891.370 $ | +16.799.233 $ | +207,6 % | 1 | 8.092.137 $ | -609.484 $ | -7,0 % | 1 |
| TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | → 0 | Neutral | 6.776.000 $ | -13.795.012 $ | -67,1 % | 1 | 20.571.012 $ | +7.547.079 $ | +57,9 % | 1 | 13.023.933 $ | +2.721.933 $ | +26,4 % | 1 |
| REPLIGEN CORP | RGEN | → 0 | Neutral | 10.615.032 $ | -7.755.882 $ | -42,2 % | 1 | 18.370.914 $ | +10.128.756 $ | +122,9 % | 1 | 8.242.158 $ | +5.127.647 $ | +164,6 % | 1 |
| PALVELLA THERAPEUTICS, INC. | PVLA | → 0 | Schwach | 10.697.400 $ | -7.010.500 $ | -39,6 % | 1 | 17.707.900 $ | +15.687.769 $ | +776,6 % | 1 | 2.020.131 $ | +2.020.131 $ | 1 | |
| Aktis Oncology, Inc. | AKTS | → 0 | 15.605.766 $ | -1.562.493 $ | -9,1 % | 1 | 17.168.259 $ | +17.168.259 $ | 1 | ||||||
| Medtronic plc | MDT | → 0 | Neutral | 5.476.100 $ | -11.285.900 $ | -67,3 % | 1 | 16.762.000 $ | +6.425.944 $ | +62,2 % | 1 | 10.336.056 $ | -7.816.688 $ | -43,1 % | 1 |
| Vir Biotechnology, Inc. | VIR | → 0 | Neutral | 5.291.667 $ | -9.546.483 $ | -64,3 % | 1 | 14.838.150 $ | +14.838.150 $ | 1 | |||||
| IMMUNIC, INC. | IMUX | → 0 | Schwach | 10.296.993 $ | -3.584.185 $ | -25,8 % | 1 | 13.881.178 $ | +11.373.102 $ | +453,5 % | 1 | 2.508.076 $ | -1.634.925 $ | -39,5 % | 1 |
| DEXCOM INC | DXCM | → 0 | Neutral | 6.735.000 $ | -4.872.000 $ | -42,0 % | 1 | 11.607.000 $ | +11.607.000 $ | 1 | |||||
| BOSTON SCIENTIFIC CORP | BSX | → 0 | Neutral | 3.414.400 $ | -3.807.200 $ | -52,7 % | 1 | 7.221.600 $ | -3.695.975 $ | -33,9 % | 1 | 10.917.575 $ | -5.123.034 $ | -31,9 % | 1 |
| Mobia Medical, Inc. | MOBI | → 0 | Neutral | 10.696.979 $ | +10.696.979 $ | 1 | |||||||||
| Senseonics Holdings, Inc. | SENS | → 0 | Neutral | 9.088.000 $ | +9.088.000 $ | 1 | |||||||||
| Karyopharm Therapeutics Inc. | KPTI | → 0 | Sehr schwach | 9.032.238 $ | +2.595.513 $ | +40,3 % | 1 | 6.436.725 $ | +5.446.319 $ | +549,9 % | 1 | 990.406 $ | +110.344 $ | +12,5 % | 1 |
| ALNYLAM PHARMACEUTICALS, INC. | ALNY | → 0 | Neutral | 8.350.650 $ | +8.350.650 $ | 1 | |||||||||
| Encompass Health Corp | EHC | → 0 | Neutral | 4.245.360 $ | -4.017.300 $ | -48,6 % | 1 | 8.262.660 $ | +4.908.636 $ | +146,4 % | 1 | 3.354.024 $ | -1.968.114 $ | -37,0 % | 1 |
| MCKESSON CORP | MCK | → 0 | Stark | 7.809.161 $ | +3.328.429 $ | +74,3 % | 1 | ||||||||
| TENAX THERAPEUTICS, INC. | TENX | → 0 | Schwach | 3.869.340 $ | -3.069.840 $ | -44,2 % | 1 | 6.939.180 $ | +6.939.180 $ | 1 | |||||
| Tempus AI, Inc. | TEM | → 0 | Schwach | 6.082.650 $ | +1.345.950 $ | +28,4 % | 1 | 4.736.700 $ | +4.736.700 $ | 1 | |||||
| ICON PLC | ICLR | → 0 | Neutral | 3.663.840 $ | -2.367.642 $ | -39,3 % | 1 | 6.031.482 $ | +6.031.482 $ | 1 | |||||
| HUMANA INC | HUM | → 0 | Neutral | 5.911.000 $ | +5.911.000 $ | 1 | |||||||||
| AGILENT TECHNOLOGIES, INC. | A | → 0 | Neutral | 5.646.905 $ | +5.646.905 $ | 1 | |||||||||
| Phathom Pharmaceuticals, Inc. | PHAT | → 0 | Neutral | 2.170.000 $ | -3.393.891 $ | -61,0 % | 1 | 5.563.891 $ | +2.145.090 $ | +62,7 % | 1 | 3.418.801 $ | -182.819 $ | -5,1 % | 1 |
| GILEAD SCIENCES, INC. | GILD | → 0 | Stark | 2.526.800 $ | -2.877.400 $ | -53,2 % | 1 | 5.404.200 $ | +5.404.200 $ | 1 | |||||
| Satellos Bioscience Inc. | MSLE | → 0 | Neutral | 3.014.904 $ | -2.250.999 $ | -42,7 % | 1 | 5.265.903 $ | +5.265.903 $ | 1 | |||||
| Structure Therapeutics Inc. | GPCR | → 0 | Schwach | 5.259.660 $ | +1.824.060 $ | +53,1 % | 1 | 3.435.600 $ | +3.435.600 $ | 1 | |||||
| PFIZER INC | PFE | → 0 | Stark | 5.069.640 $ | -4.266.232 $ | -45,7 % | 1 | ||||||||
| CENTENE CORP | CNC | → 0 | Sehr stark | 2.291.800 $ | -2.621.510 $ | -53,4 % | 1 | 4.913.310 $ | +4.913.310 $ | 1 | |||||
| Kenvue Inc. | KVUE | → 0 | Stark | 1.724.000 $ | -2.291.800 $ | -57,1 % | 1 | 4.015.800 $ | -288.396 $ | -6,7 % | 1 | ||||
| DANAHER CORP /DE/ | DHR | → 0 | Neutral | 3.891.640 $ | -6.953.182 $ | -64,1 % | 1 | ||||||||
| THERMO FISHER SCIENTIFIC INC. | TMO | → 0 | Neutral | 3.882.315 $ | -5.284.563 $ | -57,6 % | 1 | ||||||||
| SCYNEXIS INC | SCYX | → 0 | Neutral | 1.059.038 $ | -2.785.580 $ | -72,5 % | 1 | 3.844.618 $ | +2.528.176 $ | +192,0 % | 1 | 1.316.442 $ | -1.263.465 $ | -49,0 % | 1 |
| Nuvectis Pharma, Inc. | NVCT | → 0 | Neutral | 3.678.000 $ | +3.678.000 $ | 1 | |||||||||
| Natera, Inc. | NTRA | → 0 | Neutral | 3.655.350 $ | +952.088 $ | +35,2 % | 1 | 2.703.262 $ | -8.629.026 $ | -76,1 % | 1 | ||||
| INSULET CORP | PODD | → 0 | Neutral | 3.654.000 $ | +1.932.600 $ | +112,3 % | 1 | 1.721.400 $ | +1.721.400 $ | 1 | |||||
| Corvus Pharmaceuticals, Inc. | CRVS | → 0 | Neutral | 1.195.200 $ | -2.234.100 $ | -65,1 % | 1 | 3.429.300 $ | +3.429.300 $ | 1 | |||||
| NOVO NORDISK A S | NVO | → 0 | Stark | 3.424.224 $ | +3.424.224 $ | 1 | |||||||||
| Cigna Group | CI | → 0 | Sehr stark | 3.192.668 $ | -1.592.282 $ | -33,3 % | 1 | ||||||||
| Cencora, Inc. | COR | → 0 | Neutral | 3.174.850 $ | -2.763.220 $ | -46,5 % | 1 | ||||||||
| INSMED Inc | INSM | → 0 | Schwach | 3.080.508 $ | +1.409.992 $ | +84,4 % | 1 | ||||||||
| WATERS CORP /DE/ | WAT | → 0 | Stark | 3.076.623 $ | +3.076.623 $ | 1 | |||||||||
| Alamar Biosciences, Inc. | ALMR | → 0 | Neutral | 2.979.900 $ | +2.979.900 $ | 1 | |||||||||
| Hims & Hers Health, Inc. | HIMS | → 0 | Neutral | 2.915.500 $ | +2.915.500 $ | 1 | |||||||||
| ACADIA PHARMACEUTICALS INC | ACAD | → 0 | Neutral | 579.754 $ | -2.275.545 $ | -79,7 % | 1 | 2.855.299 $ | -217.661 $ | -7,1 % | 1 | ||||
| GENMAB A/S | GMAB | → 0 | Neutral | 1.373.500 $ | -1.294.000 $ | -48,5 % | 1 | 2.667.500 $ | -166.100 $ | -5,9 % | 1 | 2.833.600 $ | -4.775.627 $ | -62,8 % | 1 |
| CORCEPT THERAPEUTICS INC | CORT | → 0 | Neutral | 2.604.900 $ | +1.839.300 $ | +240,2 % | 1 | 765.600 $ | +765.600 $ | 1 | |||||
| Acadia Healthcare Company, Inc. | ACHC | → 0 | Neutral | 2.398.110 $ | +2.398.110 $ | 1 | |||||||||
| Integer Holdings Corp | ITGR | → 0 | Stark | 2.337.214 $ | +2.337.214 $ | 1 | |||||||||
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. | CRL | → 0 | Neutral | 2.267.900 $ | +598.200 $ | +35,8 % | 1 | 1.669.700 $ | +1.669.700 $ | 1 | |||||
| Avalyn Pharma Inc. | AVLN | → 0 | Neutral | 1.975.200 $ | +1.975.200 $ | 1 | |||||||||
| Intellia Therapeutics, Inc. | NTLA | → 0 | Schwach | 1.269.000 $ | -703.500 $ | -35,7 % | 1 | 1.972.500 $ | +1.972.500 $ | 1 | |||||
| PELOTON INTERACTIVE, INC. | PTON | → 0 | Stark | 591.000 $ | -1.357.000 $ | -69,7 % | 1 | 1.948.000 $ | +1.948.000 $ | 1 | |||||
| Oddity Tech Ltd | ODD | → 0 | Neutral | 1.059.100 $ | -879.900 $ | -45,4 % | 1 | 1.939.000 $ | +1.939.000 $ | 1 | |||||
| Kailera Therapeutics, Inc. | KLRA | → 0 | Neutral | 1.762.400 $ | +1.762.400 $ | 1 | |||||||||
| Anteris Technologies Global Corp. | AVR | → 0 | Neutral | 1.755.000 $ | +1.755.000 $ | 1 | |||||||||
| MoonLake Immunotherapeutics | MLTX | → 0 | Neutral | 1.751.000 $ | +1.751.000 $ | 1 | |||||||||
| HEALTHEQUITY, INC. | HQY | → 0 | Stark | 1.548.209 $ | -849.472 $ | -35,4 % | 1 | ||||||||
| Revolution Medicines, Inc. | RVMD | → 0 | Neutral | 1.458.750 $ | +1.458.750 $ | 1 | |||||||||
| Abivax S.A. | ABVX | → 0 | Neutral | 1.113.500 $ | +1.113.500 $ | 1 | |||||||||
| Arbutus Biopharma Corp | ABUS | → 0 | Schwach | 1.087.500 $ | +1.087.500 $ | 1 | |||||||||
| UNITEDHEALTH GROUP INC | UNH | → 0 | Sehr stark | 1.028.242 $ | -5.118.098 $ | -83,3 % | 1 | ||||||||
| Evommune, Inc. | EVMN | → 0 | Neutral | 996.750 $ | +996.750 $ | 1 | |||||||||
| IQVIA HOLDINGS INC. | IQV | → 0 | Neutral | 991.804 $ | +991.804 $ | 1 | |||||||||
| ABBOTT LABORATORIES | ABT | → 0 | Neutral | 907.400 $ | -500 $ | -0,1 % | 1 | 907.900 $ | +907.900 $ | 1 | |||||
| BridgeBio Oncology Therapeutics, Inc. | BBOT | → 0 | Schwach | 334.160 $ | -427.128 $ | -56,1 % | 1 | 761.288 $ | +761.288 $ | 1 | |||||
| BridgeBio Pharma, Inc. | BBIO | → 0 | Schwach | 744.800 $ | +33.700 $ | +4,7 % | 1 | 711.100 $ | +711.100 $ | 1 | |||||
| Legend Biotech Corp | LEGN | → 0 | Neutral | 433.200 $ | +80.400 $ | +22,8 % | 1 | 352.800 $ | +352.800 $ | 1 | |||||
| Savara Inc | SVRA | → 0 | Schwach | 308.000 $ | +46.000 $ | +17,6 % | 1 | 262.000 $ | +262.000 $ | 1 | |||||
| Trevi Therapeutics, Inc. | TRVI | → 0 | Neutral | 124.209 $ | -46.887 $ | -27,4 % | 1 | 171.096 $ | +171.096 $ | 1 | |||||
| Gesamt | 624.441.478 $ | -279.719.560 $ | -26,4 % | 45 | 935.701.174 $ | +640.736.346 $ | +210,1 % | 52 | 346.693.009 $ | -27.221.291 $ | -6,5 % | 39 | |||